se ha leído el artículo
array:24 [ "pii" => "S1578219017303815" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.09.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1803" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:4-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 317 "formatos" => array:3 [ "EPUB" => 18 "HTML" => 224 "PDF" => 75 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017305173" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.09.004" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1803" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:4-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1046 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 861 "PDF" => 183 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ARTÍCULO DE OPINIÓN</span>" "titulo" => "Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "4" "paginaFinal" => "5" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Moreno-Ramírez, G. Romero-Aguilera, P. Pasquali, S. Vaño, L. Ríos-Buceta, J. Malvehy, R. Taberner, L. Ferrándiz" "autores" => array:9 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Moreno-Ramírez" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Romero-Aguilera" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Pasquali" ] 3 => array:2 [ "nombre" => "S." "apellidos" => "Vaño" ] 4 => array:2 [ "nombre" => "L." "apellidos" => "Ríos-Buceta" ] 5 => array:2 [ "nombre" => "J." "apellidos" => "Malvehy" ] 6 => array:2 [ "nombre" => "R." "apellidos" => "Taberner" ] 7 => array:2 [ "nombre" => "L." "apellidos" => "Ferrándiz" ] 8 => array:1 [ "colaborador" => "Grupo de e-Dermatología e Imagen de la Academia Española de Dermatología y Venereología" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017303815" "doi" => "10.1016/j.adengl.2017.09.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303815?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017305173?idApp=UINPBA000044" "url" => "/00017310/0000010900000001/v1_201801020548/S0001731017305173/v1_201801020548/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017303591" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.003" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1675" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2018;109:6-23" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 504 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 402 "PDF" => 85 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Treatment of Malignant Cutaneous Adnexal Neoplasms" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "6" "paginaFinal" => "23" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento de las neoplasias anexiales cutáneas malignas" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0045" "etiqueta" => "Figure 9" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr9.jpeg" "Alto" => 1387 "Ancho" => 1839 "Tamanyo" => 864485 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Histopathologic characteristics of spiradenocarcinoma. A, Panoramic view showing a spiradenoma in the dermis and a spiradenocarcinoma nodule in the subcutaneous tissue. B, The nodule is formed by a sheet of neoplastic cells. C, Note the pleomorphic nuclei and frequent mitotic figures in the neoplastic cells. D. High-magnification view of neoplastic cells, several of which are in mitosis. (Hematoxylin-eosin, original magnification ×10 [A], ×40 [B], ×200 [C], ×400 [D]).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Bernárdez, L. Requena" "autores" => array:2 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Bernárdez" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Requena" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017302077" "doi" => "10.1016/j.ad.2017.04.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302077?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303591?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303591/v1_201801020547/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S157821901730358X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1770" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:2-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 309 "formatos" => array:3 [ "EPUB" => 22 "HTML" => 207 "PDF" => 80 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Contact Dermatitis to Topical Antiseptics: The Position of Mercromina Film®" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "2" "paginaFinal" => "3" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatitis de contacto a antisépticos tópicos. ¿Qué posición ocupa la Mercromina Film®?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Navarro-Triviño" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Navarro-Triviño" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017304611" "doi" => "10.1016/j.ad.2017.08.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017304611?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730358X?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S157821901730358X/v1_201801020547/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>" "titulo" => "Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "4" "paginaFinal" => "5" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "D. Moreno-Ramírez, G. Romero-Aguilera, P. Pasquali, S. Vaño, L. Ríos-Buceta, J. Malvehy, R. Taberner, L. Ferrándiz" "autores" => array:9 [ 0 => array:4 [ "nombre" => "D." "apellidos" => "Moreno-Ramírez" "email" => array:2 [ 0 => "david.moreno.ramirez.sspa@juntadeandalucia.es" 1 => "dmoreno@e-derma.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "G." "apellidos" => "Romero-Aguilera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "P." "apellidos" => "Pasquali" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "S." "apellidos" => "Vaño" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "L." "apellidos" => "Ríos-Buceta" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "J." "apellidos" => "Malvehy" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "R." "apellidos" => "Taberner" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "L." "apellidos" => "Ferrándiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 8 => array:1 [ "colaborador" => "e-Dermatology and Imaging Group of the Spanish Academy of Dermatology and Venereology" ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Pius de Valls, Valls, Tarragona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Junta Directiva, Academia Española de Dermatología y Venereología, Madrid, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Clínic, Barcelona, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Dermatología Hospital Son Llàzter, Palma de Mallorca, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Telemedicine is a reality in healthcare today and is considered to be of strategic importance by the World Health Organization.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a> Telemedicine improves the provision of healthcare services in areas with poor access to medical resources and enhances the quality of care in areas with better access. Teledermatology (TD) is one of the most common applications of telemedicine.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">During the past decade, Spain has become a world leader in TD services. Between 2009 and 2014, the number of TD programs in Spain increased significantly.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">TD has been shown to improve patient access to specialized care for specific skin conditions and to dermatologic care in general. At the same time, TD has also encountered obstacles and barriers that may have limited its use on a larger scale.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The Spanish Academy of Dermatology and Venereology (AEDV) supports the rational application of TD to improve the quality of care for skin diseases provided that it meets a series of important criteria. The association specifies that the practice of TD must always comply with the following set of basic standards.<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0025" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD refers to the use of information and communication technologies (ICT) in the care of skin diseases</span>. TD is a complementary tool used in the practice of dermatology and, as such, must be used or coordinated solely by specialist dermatologists with the necessary skills and training in e-health processes and the use of ICT in medical practice.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0030" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Leadership of the dermatologist.</span> The leadership of a dermatologist must be a fundamental prerequisite in the design and implementation of all TD programs. All programs and initiatives using ICT to provide dermatologic care must be led by a dermatologist at every stage. The dermatologist must play a coordinating role in multidisciplinary teams developing or using TD.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0035" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">All TD programs must include the support of a dermatologist who is available for in-person consultations.</span> TD is complementary to the practice of face-to-face dermatology. It can be used to facilitate triage, prioritization, and patient referral and is in no case a substitute for the availability, when necessary, of an in-person consultation with a dermatologist.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0040" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD should be used to respond to an identified need for improvement in a healthcare process.</span> As a complementary tool for delivering dermatologic care, TD should be integrated into the overall care process to respond to the specific needs identified (accessibility, prioritization, coordination between care levels, follow-up of patients with chronic disease, continuous training, etc.). It is essential in the design of TD programs to identify the stages and activities in a particular process that are likely to be improved by the use of the methodology. The practice of TD should always be regulated by clearly defined work procedures and referral protocols.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">5.</span><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD must be incorporated into the organization's portfolio of services.</span> TD activity must be incorporated into the authorized portfolio of services of both the dermatology service providers and other participants (primary care centers, other hospital departments). All TD activity should be part of a program that is formally recognized and authorized by the relevant hospital, health care center, and/or health authority.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">6.</span><p id="par0050" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD programs must be allocated specific and adequate resources to ensure good practice.</span> In the programmed schedule of activities of a dermatology department or clinic, time must be specifically allocated for all of the work involved in a TD program (teleconsultations, training, resolving technical problems, etc.). All TD programs must use equipment and software designed for the specific purpose to ensure ease of use for those operating the system and secure data transmission. TD applications must be integrated into the corporate information system.</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">7.</span><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD programs must be supported by comprehensive training programs.</span> All professionals participating in a TD program must complete a training program specific to their role: operators (training in obtaining images, user interfaces, etc.), primary care physicians or other specialist physicians (training in criteria for teleconsultation, referral paths etc.), dermatologists (training in decision making, the user interface, etc.). TD training programs must be updated and maintained as long as the program is in operation.</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">8.</span><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The use of TD must be monitored by way of an integrated validation and quality control program.</span> All TD programs must undergo an initial validation process in all the dimensions that will be continuously monitored (efficacy, safety, diagnostic validity, efficiency, and user satisfaction). Monitoring is also essential to identify errors and deviations from the protocol and to facilitate a quality-control system that will ensure ongoing improvement. AEDV will publish guidelines on clinical practice using TD in order to establish standards for the process and to provide clinical guidelines for dermatologists.</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">9.</span><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The modality of TD used in each case must be the one that can provide the most efficiency and clinical safety for the specific healthcare need to be met.</span> All the TD methodologies (store-and-forward, real time, mixed, mobile) and modalities of interaction between the participants (primary TD, patient-dermatologist; secondary TD, primary care physician-dermatologist; tertiary, dermatologist-dermatologist) have been shown to have strengths and weaknesses. Physicians should use the method best adapted to the health condition or group of conditions being addressed. Selecting the process in which TD has shown the greatest efficacy is the best guarantee of clinical safety for both patient and dermatologist.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel"><span class="elsevierStyleItalic">10.</span></span><p id="par0070" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The TD process must respect the patients’ right to choice and ensure their confidentiality at all times.</span> The practice of TD must always include a procedure that defines the purposes and uses of the images obtained and transmitted. All applications used in TD must fulfil the confidentiality and privacy requirements required under current personal data protection legislation<span class="elsevierStyleItalic">.</span> It is advisable to specify the limitations of TD in a safeguard clause, which should be included in all the reports issued by clinicians.</p></li></ul></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Moreno-Ramírez D, Romero-Aguilera G, Pasquali P, Vaño S, Ríos-Buceta L, Malvehy J, et al. Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología. Actas Dermosifiliogr. 2018;109:4–5.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Références" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:2 [ 0 => array:3 [ "identificador" => "bib0015" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Telemedicine: Opportunities and developments in Member States: Report on the second global survey on eHealth 2009. Global observatory for eHealth Series, 2. WHO Library Cataloguing in-Publication Data. Geneva, Switzerland; 2011 [cited 26 Abril 2016]. Available from: <a href="http://apps.who.int/iris/bitstream/10665/44497/1/9789241564144_eng.pdf">http://apps.who.int/iris/bitstream/10665/44497/1/9789241564144_eng.pdf</a>" ] ] ] 1 => array:3 [ "identificador" => "bib0020" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Teledermatología, del debate a la calma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Moreno-Ramírez" 1 => "G. Romero-Aguilera" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2016.01.006" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr." "fecha" => "2016" "volumen" => "107" "paginaInicial" => "366" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26956401" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack326620" "titulo" => "Acknowledgments" "texto" => "<p id="par0075" class="elsevierStylePara elsevierViewall">This document was drawn up by the e-Dermatology and Imaging Group and the Board of Directors of the Spanish Academy of Dermatology and Venereology.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303815/v1_201801020547/en/main.assets" "Apartado" => array:4 [ "identificador" => "6152" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000001/v1_201801020547/S1578219017303815/v1_201801020547/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303815?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 6 | 6 | 12 |
2024 Octubre | 83 | 39 | 122 |
2024 Septiembre | 80 | 20 | 100 |
2024 Agosto | 103 | 48 | 151 |
2024 Julio | 65 | 37 | 102 |
2024 Junio | 77 | 44 | 121 |
2024 Mayo | 65 | 35 | 100 |
2024 Abril | 71 | 31 | 102 |
2024 Marzo | 74 | 31 | 105 |
2024 Febrero | 64 | 32 | 96 |
2024 Enero | 55 | 33 | 88 |
2023 Diciembre | 45 | 20 | 65 |
2023 Noviembre | 84 | 32 | 116 |
2023 Octubre | 76 | 21 | 97 |
2023 Septiembre | 57 | 27 | 84 |
2023 Agosto | 33 | 16 | 49 |
2023 Julio | 67 | 27 | 94 |
2023 Junio | 47 | 20 | 67 |
2023 Mayo | 58 | 26 | 84 |
2023 Abril | 48 | 26 | 74 |
2023 Marzo | 47 | 29 | 76 |
2023 Febrero | 49 | 36 | 85 |
2023 Enero | 48 | 35 | 83 |
2022 Diciembre | 46 | 42 | 88 |
2022 Noviembre | 39 | 21 | 60 |
2022 Octubre | 25 | 22 | 47 |
2022 Septiembre | 27 | 41 | 68 |
2022 Agosto | 34 | 37 | 71 |
2022 Julio | 26 | 36 | 62 |
2022 Junio | 21 | 19 | 40 |
2022 Mayo | 37 | 43 | 80 |
2022 Abril | 47 | 37 | 84 |
2022 Marzo | 55 | 61 | 116 |
2022 Febrero | 35 | 25 | 60 |
2022 Enero | 46 | 42 | 88 |
2021 Diciembre | 46 | 44 | 90 |
2021 Noviembre | 54 | 54 | 108 |
2021 Octubre | 66 | 65 | 131 |
2021 Septiembre | 41 | 53 | 94 |
2021 Agosto | 54 | 48 | 102 |
2021 Julio | 35 | 38 | 73 |
2021 Junio | 26 | 45 | 71 |
2021 Mayo | 37 | 53 | 90 |
2021 Abril | 71 | 68 | 139 |
2021 Marzo | 76 | 45 | 121 |
2021 Febrero | 60 | 40 | 100 |
2021 Enero | 48 | 45 | 93 |
2020 Diciembre | 32 | 30 | 62 |
2020 Noviembre | 39 | 43 | 82 |
2020 Octubre | 28 | 26 | 54 |
2020 Septiembre | 38 | 25 | 63 |
2020 Agosto | 28 | 26 | 54 |
2020 Julio | 33 | 30 | 63 |
2020 Junio | 38 | 52 | 90 |
2020 Mayo | 24 | 18 | 42 |
2020 Abril | 24 | 20 | 44 |
2020 Marzo | 27 | 19 | 46 |
2020 Febrero | 2 | 1 | 3 |
2020 Enero | 4 | 0 | 4 |
2019 Diciembre | 8 | 0 | 8 |
2019 Noviembre | 4 | 0 | 4 |
2019 Septiembre | 8 | 0 | 8 |
2019 Agosto | 4 | 0 | 4 |
2019 Julio | 4 | 0 | 4 |
2019 Junio | 6 | 0 | 6 |
2019 Mayo | 4 | 0 | 4 |
2019 Abril | 2 | 0 | 2 |
2019 Marzo | 4 | 0 | 4 |
2019 Febrero | 1 | 0 | 1 |
2019 Enero | 1 | 0 | 1 |
2018 Diciembre | 10 | 0 | 10 |
2018 Noviembre | 11 | 0 | 11 |
2018 Octubre | 15 | 0 | 15 |
2018 Septiembre | 5 | 0 | 5 |
2018 Marzo | 0 | 1 | 1 |
2018 Febrero | 53 | 28 | 81 |
2018 Enero | 76 | 39 | 115 |
2017 Diciembre | 3 | 7 | 10 |